Compare Analog Devices, Inc. (ADI) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Analog Devices, Inc. vs Citius Pharmaceuticals Inc — how do they compare? Analog Devices, Inc. trades at $389.54 (market cap $187.67B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Analog Devices, Inc. is far larger — about 9378.8× Citius Pharmaceuticals Inc's market cap, and Analog Devices, Inc. pays a 1.14% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ADI | CTXR | |
|---|---|---|
Market Cap | $187.67B | $20.01M |
Sector | Technology | Health |
52-Week High | $445.48 | $1.82 |
52-Week Low | $225.20 | $0.48 |
Enterprise Value | $192.92B | $16.23M |
Dividend Yield | 1.14% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CTXR is trading at $0.68, up 6.28% today, with a bullish technical signal from moving averages. The company shows strong commercial momentum with LYMPHIR cancer treatment revenue reaching $5.6 million in H1 2026, though it remains unprofitable with a -823% net margin. Analyst consensus is strongly bullish with 83% buy ratings.
The outlook depends on LYMPHIR's commercial success offsetting deep losses. Near-term catalysts include expanded market access and combination therapy data, but high cash burn and execution risks require monitoring. The stock offers speculative growth potential in oncology but carries significant financial risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Analog Devices, Inc.
Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.
Read more on ADI →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
